SkinHealth Systems annual r&d spending
2019
2020
2021
2022
2023
2024
2025
SkinHealth Systems R&D Spending Growth & History (SKIN)
SkinHealth Systems's r&d spending was $5.6M for fiscal 2025.
View full SkinHealth Systems company overviewSkinHealth Systems annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.6M | −$668,000 | −10.61% |
| 2024 | 2024-12-31 | $6.3M | −$3.8M | −37.68% |
| 2023 | 2023-12-31 | $10.1M | $1.7M | +19.64% |
| 2022 | 2022-12-31 | $8.4M | $249,000 | +3.04% |
| 2021 | 2021-12-31 | $8.2M | $4.8M | +140.39% |
| 2020 | 2020-12-31 | $3.4M | −$1.2M | −26.12% |
| 2019 | 2019-12-31 | $4.6M | — | — |
SkinHealth Systems quarterly r&d spending
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.4M | $156,000 | +12.47% |
| Q1 2026 | 2026-03-31 | $1.1M | $104,000 | +10.42% |
| Q4 2025 | 2025-12-31 | $1.7M | $459,000 | +37.56% |
| Q3 2025 | 2025-09-30 | $1.7M | $590,000 | +53.25% |
| Q2 2025 | 2025-06-30 | $1.3M | $92,000 | +7.94% |
| Q1 2025 | 2025-03-31 | $998,000 | −$1.8M | −64.45% |
| Q4 2024 | 2024-12-31 | $1.2M | −$1.8M | −59.88% |
| Q3 2024 | 2024-09-30 | $1.1M | −$731,000 | −39.75% |
| Q2 2024 | 2024-06-30 | $1.2M | −$1.7M | −59.77% |
| Q1 2024 | 2024-03-31 | $2.8M | $471,000 | +20.16% |
| Q4 2023 | 2023-12-31 | $3.0M | $1.6M | +110.65% |
| Q3 2023 | 2023-09-30 | $1.8M | −$328,000 | −15.14% |
| Q2 2023 | 2023-06-30 | $2.9M | $280,000 | +10.77% |
| Q1 2023 | 2023-03-31 | $2.3M | $106,000 | +4.75% |
| Q4 2022 | 2022-12-31 | $1.4M | −$429,000 | −22.88% |
| Q3 2022 | 2022-09-30 | $2.2M | $287,000 | +15.27% |
| Q2 2022 | 2022-06-30 | $2.6M | −$387,000 | −12.95% |
| Q1 2022 | 2022-03-31 | $2.2M | $778,000 | +53.58% |
| Q4 2021 | 2021-12-31 | $1.9M | — | — |
| Q3 2021 | 2021-09-30 | $1.9M | $1.3M | +225.82% |
| Q2 2021 | 2021-06-30 | $3.0M | $2.4M | +400.50% |
| Q1 2021 | 2021-03-31 | $1.5M | — | — |
| Q3 2020 | 2020-09-30 | $577,000 | — | — |
| Q2 2020 | 2020-06-30 | $597,000 | — | — |
SkinHealth Systems r&d spending trends
Over the last five fiscal years, SkinHealth Systems's r&d spending increased from $3.4M to $5.6M, a change of $2.2M. The latest reported quarter, Q2 2026, shows $1.4M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SkinHealth Systems source filings ↗